Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05178576
Title A Single Arm Phase II Study to Evaluate Treatment With Gevokizumab in Patients With Stage II/III Colon Cancer Who Are ctDNA-positive After Curative Surgery and Adjuvant Chemotherapy
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors NSABP Foundation Inc
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
UF Health Davis Cancer Pavilion and Shands Med Plaza Gainesville Florida 32608 United States Details
University of Iowa Iowa City Iowa 52242 United States Details
Rutgers Cancer Institute of New Jersey New Brunswick New Jersey 08903 United States Details
Wake Forest Baptist Health Winston-Salem North Carolina 27157 United States Details
AHN Cancer Institute Pittsburgh Pennsylvania 15212 United States Details
*Shaded cells indicate that there was no data available from for the field